RxDoctor Payments Data

Kevin Williams, PA

Physician Assistant · Charlotte, NCNPI 1053312082

Payments from drug & device makers

$10,557in general payments, 2019–2025

Across 114 payments — averaging $92.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$8K
  • AbbVie$950
  • AstraZeneca$325
  • Novo Nordisk$286
  • Amgen$262
  • Biohaven Pharmaceuticals, Inc.$176
  • plus $846 from 15 others

What the payments were for

  • Consulting fees$7,71373%
  • Food & beverage$2,79927%
  • Education$450%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,557 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$18,244
Medicare patients
124
Services billed
263

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide54$68,569
TrulicityDulaglutide28$28,550
FarxigaDapagliflozin Propanediol28$17,015
EliquisApixaban16$14,323
LinzessLinaclotide13$6,987
VascepaIcosapent Ethyl11$3,058
Atorvastatin Calcium140$895
Albuterol Sulfate HfaAlbuterol Sulfate36$781
Gabapentin46$780
Amlodipine Besylate135$600
Lisinopril64$542
Rosuvastatin Calcium45$501
Omeprazole56$500
Losartan Potassium53$409
Levothyroxine Sodium62$385

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$286$68,56954 claims
Lilly USA, LLCTrulicity$80$28,55028 claims
AstraZenecaFarxiga$325$17,01528 claims
PfizerEliquis$46$14,32316 claims
AbbVieLinzess$950$6,98713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →